Drugs / SR31747A
last change Aug 2006 re-read 3 minutes ago

SR31747A

Developed for
prostate neoplasm
Investigated by
Sanofi

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00174863 Oct 2003 → Aug 2006 prostate neoplasm Sanofi Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SR31747A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00174863 ↗